Vol.

No.

August 31, 2018Aug 31, 2018

Free

DOWNLOAD THE PDF

NIH Director Francis Collins tricked into debating disguised Sacha Baron Cohen on Showtime spoof “Who Is America?”

Cover Story

Free

NIH Director Francis Collins tricked into debating disguised Sacha Baron Cohen on Showtime spoof “Who Is America?”

By Paul Goldberg

Billy Wayne Ruddick Jr., Ph.D., is a character eerily reminiscent of someone we know, a distant relative who picks political fights on Facebook and Twitter.

Conversation with The Cancer Letter Free

It took an elaborate ruse to get NIH Director Francis Collins on Sacha Baron Cohen's “Who Is America?”

By Paul Goldberg

Free

Senate spending bill gives NIH $2 billion raise

By Paul Goldberg

Free Obituary

James D. Cox, former RTOG chair, dies at 80

By Walter J. Curran

In Brief

Rosenberg, June and Allison share 2018 Albany Prize

Karen Knudsen named AAACI president-elect

Cory Wiegert named CEO of CancerLinQ LLC

Moffitt's chief information security officer named fellow to America's cybersecurity think tank

Exact Sciences, Pfizer enter into U.S. promotion agreement for Cologuard

MD Anderson, Accelerator Life Science form Magnolia Neurosciences

UCLA awarded $9.3 million to help provide prostate cancer treatment

Ana María López to lead medical oncology at Sidney Kimmel

Noriega joins Fox Chase Division of Pulmonary and Critical Care

Yahanda, Loaiza-Bonilla receive promotions at CTCA

Clinical Roundup

NCCN publishes first U.S. guidelines for rare cancers associated with pregnancy

Collection of brain cancer data accessible to global researchers

Comprehensive CAR T-cell therapy pediatric guidelines developed

University of Maryland scientists to conduct first FDA-approved study of focused ultrasound to open blood-brain barrier

Liquid biopsy could ease the way to immunotherapy for lung cancer

Drugs & Targets

Imbruvica + rituximab becomes first non-chemo combination for Waldenström's macroglobulinemia

FDA approves lenvatinib for unresectable hepatocellular carcinoma

Lenvima gets European approval for advanced, unresectable hepatocellular carcinoma

FDA approves pembrolizumab + chemo for first-line metastatic non-squamous NSCLC

FDA updates prescribing information for Keytruda, Tecentriq

Nivolumab gets accelerated approval for third-line metastatic small cell lung cancer

FDA approves Kyowa Kirin's Poteligeo for mycosis fungoides and Sézary Syndrome

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

NIH Director Francis Collins tricked into debating disguised Sacha Baron Cohen on Showtime spoof “Who Is America?”

It took an elaborate ruse to get NIH Director Francis Collins on Sacha Baron Cohen's “Who Is America?”

Senate spending bill gives NIH $2 billion raise

James D. Cox, former RTOG chair, dies at 80

In Brief

Rosenberg, June and Allison share 2018 Albany Prize

Karen Knudsen named AAACI president-elect

Cory Wiegert named CEO of CancerLinQ LLC

Moffitt's chief information security officer named fellow to America's cybersecurity think tank

Exact Sciences, Pfizer enter into U.S. promotion agreement for Cologuard

MD Anderson, Accelerator Life Science form Magnolia Neurosciences

UCLA awarded $9.3 million to help provide prostate cancer treatment

Ana María López to lead medical oncology at Sidney Kimmel

Noriega joins Fox Chase Division of Pulmonary and Critical Care

Yahanda, Loaiza-Bonilla receive promotions at CTCA

Clinical Roundup

NCCN publishes first U.S. guidelines for rare cancers associated with pregnancy

Collection of brain cancer data accessible to global researchers

Comprehensive CAR T-cell therapy pediatric guidelines developed

University of Maryland scientists to conduct first FDA-approved study of focused ultrasound to open blood-brain barrier

Liquid biopsy could ease the way to immunotherapy for lung cancer

Drugs & Targets

Imbruvica + rituximab becomes first non-chemo combination for Waldenström's macroglobulinemia

FDA approves lenvatinib for unresectable hepatocellular carcinoma

Lenvima gets European approval for advanced, unresectable hepatocellular carcinoma

FDA approves pembrolizumab + chemo for first-line metastatic non-squamous NSCLC

FDA updates prescribing information for Keytruda, Tecentriq

Nivolumab gets accelerated approval for third-line metastatic small cell lung cancer

FDA approves Kyowa Kirin's Poteligeo for mycosis fungoides and Sézary Syndrome

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login